Rhizome AI vs. RegDesk

Rhizome functions as a collaborative AI regulatory partner specifically tailored for teams working within the life sciences industry. Although conventional AI assistants boast impressive features, the unique demands of an AI tool tasked with guiding decisions on drugs or devices valued at over $100 million necessitate a more specialized approach. Our agents exclusively rely on factual information extracted from primary source documents, guaranteeing that their validation does not come from memory; we evaluate their effectiveness based on this standard, and there have been no reported inaccuracies in the last 18 months. The foundational databases that inform regulatory choices, such as Drugs@FDA, guidance documents, clinicaltrials.gov, and various standards, often present challenges for computer searches, with many existing solely as image-based PDFs. We have successfully developed methods to ingest and analyze this vast array of information, which includes over 75 health authority databases across more than 12 markets as of August 2026, a figure that continues to expand. This translates to more than 45 million documents that our agents can access and query in depth. Unlike a general assistant that may only consult 5 to 10 sources, Rhizome has the capability to analyze hundreds or even thousands of documents, as the crucial inquiry often posed is, "Have we missed a relevant precedent?" By employing this exhaustive methodology, we ensure that our users receive the most thorough and precise information available, ultimately empowering them to make informed decisions in their critical work. With a commitment to continuous improvement, we consistently enhance our processes to adapt to the evolving landscape of regulatory requirements.

RegDesk stands out as the leading RIMS platform enhanced by AI, tailored specifically for Medical Device, Pharmaceutical, and IVD companies. • Our unique Regulatory Intelligence encompasses data from over 120 countries, all presented in a uniform format, and includes timely alerts regarding regulatory updates. • With our AI-driven Application Builder, regulatory affairs teams can efficiently create and submit global applications in a fraction of the usual time. • The Change Assessment feature enables RA teams to evaluate the implications of changes on current products and determine the necessary actions. • Our Distributor Collaboration tool facilitates smooth workflows for communication and document sharing with external partners. • The Standards Management function simplifies the process for RA teams to locate and oversee both international and country-specific standards. • Additionally, our Tracking & Reporting capability empowers teams to monitor regulatory initiatives worldwide, receive notifications for renewals, and quickly compile reports on key performance indicators. To learn more about our offerings, please explore our website.